
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions â written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Fludiazepam
Introduction
Overview
Overview
Fludiazepam, marketed under the brand name Erispan[1][2] is a potent benzodiazepine and 2′-fluoro derivative of diazepam,[3] originally developed by Hoffman-La Roche in the 1960s.[4] It is marketed in Japan and Taiwan in the form of 0.25Â mg tablets, making it around 40x more potent than diazepam. It exerts its pharmacological properties via enhancement of GABAergic inhibition.[5] Fludiazepam has 4 times more binding affinity for benzodiazepine receptors than diazepam.[6] It possesses anxiolytic,[7][8][9] anticonvulsant, sedative, hypnotic and skeletal muscle relaxant properties.[10]
As with all benzodiazepines, fludiazepam is used recreationally.[11]
References
References
- â Su, TP.; Chen, TJ.; Hwang, SJ.; Chou, LF.; Fan, AP.; Chen, YC. (Aug 2002). “Utilization of psychotropic drugs in Taiwan: an overview of outpatient sector in 2000”. Zhonghua Yi Xue Za Zhi (Taipei). 65 (8): 378â91. PMIDÂ 12455808.
- â “Benzodiazepine Names”. non-benzodiazepines.org.uk. Retrieved 2008-12-29.
- â Neville, GA.; Beckstead, HD.; Shurvell, HF. (Feb 1994). “A Fourier transform-Raman and infrared vibrational study of delorazepam, fludiazepam, flurazepam, and tetrazepam”. J Pharm Sci. 83 (2): 143â51. doi:10.1002/jps.2600830207. PMIDÂ 7909552.
- â US Patent 3299053 -ARYL-JH-L,X-BENZODIAZEPIN-Z(LH)-ONES
- â Tsuchiya, T.; Fukushima, H. (Apr 1978). “Effects of benzodiazepines and pentobarbitone on the gaba-ergic recurrent inhibition of hippocampal neurons”. Eur J Pharmacol. 48 (4): 421â4. doi:10.1016/0014-2999(78)90169-3. PMIDÂ 648585.
- â Nakatsuka, I.; Shimizu, H.; Asami, Y.; Katoh, T.; Hirose, A.; Yoshitake, A. (Jan 1985). “Benzodiazepines and their metabolites: relationship between binding affinity to the benzodiazepine receptor and pharmacological activity”. Life Sci. 36 (2): 113â9. doi:10.1016/0024-3205(85)90089-X. PMIDÂ 2857046.
- â Okada, S.; Ichiki, K.; Tanokuchi, S.; Ishii, K.; Hamada, H.; Ota, Z. (1994). “Effect of an anxiolytic on lipid profile in non-insulin-dependent diabetes mellitus”. J Int Med Res. 22 (6): 338â42. PMIDÂ 7895897.
- â Okada, S.; Ichiki, K.; Tanokuchi, S.; Ishii, K.; Hamada, H.; Ota, Z. (1995). “Improvement of stress reduces glycosylated haemoglobin levels in patients with type 2 diabetes”. J Int Med Res. 23 (2): 119â22. PMIDÂ 7601294.
- â Okada, S.; Ichiki, K.; Tanokuchi, S.; Ishii, K.; Hamada, H.; Ota, Z. (1995). “How blood pressure in patients with non-insulin-dependent diabetes mellitus is influenced by stress”. J Int Med Res. 23 (5): 377â80. PMIDÂ 8529781.
- â Inoue, H.; Maeno, Y.; Iwasa, M.; Matoba, R.; Nagao, M. (Sep 2000). “Screening and determination of benzodiazepines in whole blood using solid-phase extraction and gas chromatography/mass spectrometry”. Forensic Sci Int. 113 (1â3): 367â73. doi:10.1016/S0379-0738(00)00226-7. PMIDÂ 10978650.
- â Shimamine, M.; Masunari, T.; Nakahara, Y. (1993). “[Studies on identification of drugs of abuse by diode array detection. I. Screening-test and identification of benzodiazepines by HPLC-DAD with ICOS software system]”. Eisei Shikenjo Hokoku (111): 47â56. PMIDÂ 7920567.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
